ABBOTT PARK, Ill., April 20, 2012
/PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug
Administration clearance to use its iFS Advanced Femtosecond Laser to
create bow-shaped or curved arcuate incisions in corneal surgery,
including cataract surgery.
The
iFS Laser is currently used to create LASIK flaps and other corneal
incisions in the eye and is the fifth generation of IntraLase
technology, which has been used in more than 5 million procedures
worldwide.
Nearly 3 million patients undergo cataract surgery each year in the United States.
With this new clearance, the iFS Laser now gives surgeons the ability
to make precise, bladeless arcuate incisions during surgery and
customize the incision for each individual patient.
Factors
such as placement, length, depth and radius of curvature can influence
the surgeon's desired change to the cornea. These parameters can be
difficult to control through traditional incisions made by hand using
surgical knives. Now, using the iFS Laser, arcuate incisions can be
performed with greater precision, predictability and customization than
is possible with a manual technique.
source: PR Newswire
